| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress Disorders, Post-Traumatic | 110 | 2026 | 568 | 18.460 |
Why?
|
| Veterans | 68 | 2026 | 210 | 12.590 |
Why?
|
| Biomphalaria | 13 | 2025 | 18 | 6.240 |
Why?
|
| DNA Methylation | 26 | 2026 | 403 | 4.450 |
Why?
|
| Ganglia, Invertebrate | 16 | 2024 | 25 | 2.970 |
Why?
|
| Epigenesis, Genetic | 18 | 2026 | 291 | 2.610 |
Why?
|
| Schistosomiasis | 4 | 2025 | 19 | 2.310 |
Why?
|
| Genetic Predisposition to Disease | 17 | 2025 | 734 | 2.230 |
Why?
|
| Neuropeptides | 7 | 2025 | 64 | 2.210 |
Why?
|
| Schistosomiasis mansoni | 4 | 2023 | 10 | 2.210 |
Why?
|
| Genome-Wide Association Study | 17 | 2025 | 423 | 2.170 |
Why?
|
| Host-Parasite Interactions | 5 | 2023 | 79 | 2.070 |
Why?
|
| Middle Aged | 79 | 2026 | 12222 | 1.990 |
Why?
|
| Adult | 80 | 2026 | 13872 | 1.930 |
Why?
|
| Aplysia | 12 | 2025 | 20 | 1.920 |
Why?
|
| Male | 101 | 2026 | 23409 | 1.920 |
Why?
|
| Schistosoma mansoni | 7 | 2023 | 21 | 1.920 |
Why?
|
| Spouses | 6 | 2015 | 38 | 1.850 |
Why?
|
| Prefrontal Cortex | 8 | 2024 | 164 | 1.840 |
Why?
|
| gamma-Aminobutyric Acid | 6 | 2019 | 81 | 1.800 |
Why?
|
| Severity of Illness Index | 24 | 2025 | 719 | 1.740 |
Why?
|
| Humans | 130 | 2026 | 43102 | 1.690 |
Why?
|
| Mental Disorders | 8 | 2022 | 392 | 1.630 |
Why?
|
| Female | 88 | 2026 | 24698 | 1.600 |
Why?
|
| Psychopathology | 5 | 2023 | 20 | 1.560 |
Why?
|
| Dissociative Disorders | 7 | 2023 | 19 | 1.460 |
Why?
|
| Serotonin | 3 | 2024 | 123 | 1.450 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 14 | 2022 | 116 | 1.430 |
Why?
|
| Personality Disorders | 9 | 2015 | 21 | 1.420 |
Why?
|
| Glucuronidase | 3 | 2020 | 21 | 1.400 |
Why?
|
| Brachyura | 5 | 2011 | 14 | 1.400 |
Why?
|
| Neurons | 16 | 2025 | 1263 | 1.390 |
Why?
|
| Polymorphism, Single Nucleotide | 14 | 2025 | 863 | 1.330 |
Why?
|
| Combat Disorders | 8 | 2016 | 12 | 1.310 |
Why?
|
| Cerebral Cortex | 3 | 2017 | 306 | 1.310 |
Why?
|
| Dopamine | 7 | 2020 | 275 | 1.280 |
Why?
|
| Gastropoda | 2 | 2020 | 16 | 1.230 |
Why?
|
| Young Adult | 32 | 2026 | 5080 | 1.190 |
Why?
|
| Life Change Events | 11 | 2018 | 109 | 1.170 |
Why?
|
| FMRFamide | 3 | 2023 | 12 | 1.170 |
Why?
|
| Tyrosine 3-Monooxygenase | 6 | 2018 | 92 | 1.170 |
Why?
|
| Dementia | 4 | 2024 | 160 | 1.160 |
Why?
|
| Nerve Net | 4 | 2018 | 101 | 1.140 |
Why?
|
| Central Nervous System | 7 | 2025 | 152 | 1.120 |
Why?
|
| Inflammation | 8 | 2025 | 758 | 1.080 |
Why?
|
| Brain | 13 | 2026 | 1472 | 1.070 |
Why?
|
| Anxiety Disorders | 7 | 2023 | 322 | 1.070 |
Why?
|
| Aged | 38 | 2026 | 8214 | 1.000 |
Why?
|
| Alzheimer Disease | 4 | 2024 | 1001 | 1.000 |
Why?
|
| Substance-Related Disorders | 7 | 2023 | 830 | 0.980 |
Why?
|
| Military Personnel | 9 | 2024 | 110 | 0.970 |
Why?
|
| Comorbidity | 17 | 2026 | 737 | 0.960 |
Why?
|
| Fear | 7 | 2023 | 272 | 0.950 |
Why?
|
| Animals | 37 | 2025 | 16992 | 0.940 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2025 | 75 | 0.920 |
Why?
|
| Psychiatric Status Rating Scales | 12 | 2018 | 282 | 0.900 |
Why?
|
| Expressed Emotion | 3 | 2014 | 9 | 0.900 |
Why?
|
| Cholecystokinin | 1 | 2025 | 16 | 0.890 |
Why?
|
| Spouse Abuse | 3 | 2014 | 52 | 0.890 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2023 | 587 | 0.880 |
Why?
|
| MMPI | 6 | 2023 | 11 | 0.870 |
Why?
|
| Feeding Behavior | 6 | 2018 | 469 | 0.860 |
Why?
|
| Motor Neurons | 6 | 2019 | 90 | 0.840 |
Why?
|
| Aging | 8 | 2025 | 783 | 0.840 |
Why?
|
| Blood-Brain Barrier | 1 | 2026 | 173 | 0.830 |
Why?
|
| Amygdala | 6 | 2024 | 125 | 0.810 |
Why?
|
| Trematoda | 1 | 2023 | 3 | 0.810 |
Why?
|
| Cerebrovascular Circulation | 2 | 2020 | 70 | 0.800 |
Why?
|
| Genotype | 9 | 2022 | 800 | 0.790 |
Why?
|
| Waste Disposal, Fluid | 3 | 2019 | 19 | 0.780 |
Why?
|
| Stress, Psychological | 4 | 2019 | 661 | 0.760 |
Why?
|
| Sexual Partners | 3 | 2015 | 326 | 0.750 |
Why?
|
| Longitudinal Studies | 13 | 2026 | 1063 | 0.730 |
Why?
|
| Aggression | 6 | 2017 | 102 | 0.710 |
Why?
|
| Longevity | 2 | 2020 | 173 | 0.680 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2021 | 39 | 0.670 |
Why?
|
| Gyrus Cinguli | 3 | 2023 | 31 | 0.670 |
Why?
|
| Oxidative Stress | 2 | 2018 | 1003 | 0.660 |
Why?
|
| Feedback, Physiological | 2 | 2011 | 32 | 0.660 |
Why?
|
| Hippocampus | 4 | 2023 | 594 | 0.650 |
Why?
|
| Aging, Premature | 1 | 2020 | 6 | 0.650 |
Why?
|
| Catecholamines | 4 | 2014 | 45 | 0.640 |
Why?
|
| Interneurons | 7 | 2018 | 65 | 0.620 |
Why?
|
| Interpersonal Relations | 5 | 2015 | 222 | 0.610 |
Why?
|
| Nitrogen | 2 | 2017 | 84 | 0.600 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2019 | 49 | 0.600 |
Why?
|
| United States | 18 | 2026 | 5205 | 0.590 |
Why?
|
| Metabolic Diseases | 2 | 2017 | 40 | 0.580 |
Why?
|
| Personality | 6 | 2019 | 55 | 0.560 |
Why?
|
| Muscles | 1 | 2018 | 82 | 0.550 |
Why?
|
| Heart Rate | 3 | 2011 | 266 | 0.550 |
Why?
|
| Affect | 5 | 2014 | 180 | 0.550 |
Why?
|
| Executive Function | 1 | 2018 | 59 | 0.540 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 65 | 0.540 |
Why?
|
| Depersonalization | 3 | 2019 | 4 | 0.540 |
Why?
|
| Pharmacogenetics | 1 | 2018 | 67 | 0.540 |
Why?
|
| Nervous System | 2 | 2020 | 32 | 0.540 |
Why?
|
| Oxygen | 3 | 2019 | 218 | 0.540 |
Why?
|
| C-Reactive Protein | 4 | 2025 | 167 | 0.530 |
Why?
|
| Depressive Disorder | 3 | 2014 | 187 | 0.530 |
Why?
|
| Polymorphism, Genetic | 2 | 2022 | 201 | 0.520 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2017 | 18 | 0.520 |
Why?
|
| Self-Injurious Behavior | 1 | 2017 | 25 | 0.510 |
Why?
|
| Alcoholism | 4 | 2021 | 305 | 0.510 |
Why?
|
| Carbon | 2 | 2017 | 128 | 0.500 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 301 | 0.500 |
Why?
|
| Cognition | 1 | 2020 | 473 | 0.490 |
Why?
|
| Mortality | 1 | 2018 | 175 | 0.490 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2015 | 3 | 0.470 |
Why?
|
| Corpus Callosum | 1 | 2015 | 14 | 0.470 |
Why?
|
| Models, Psychological | 8 | 2018 | 140 | 0.470 |
Why?
|
| Synaptic Transmission | 6 | 2014 | 149 | 0.470 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2016 | 65 | 0.470 |
Why?
|
| Immunohistochemistry | 6 | 2019 | 934 | 0.470 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2023 | 27 | 0.460 |
Why?
|
| Memory, Short-Term | 1 | 2015 | 59 | 0.450 |
Why?
|
| Apolipoprotein E4 | 3 | 2024 | 67 | 0.450 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 35 | 0.450 |
Why?
|
| Cheek | 3 | 2007 | 13 | 0.450 |
Why?
|
| Adaptation, Psychological | 2 | 2011 | 420 | 0.450 |
Why?
|
| Models, Statistical | 4 | 2014 | 195 | 0.440 |
Why?
|
| Anger | 2 | 2014 | 27 | 0.440 |
Why?
|
| Chronic Disease | 1 | 2018 | 549 | 0.430 |
Why?
|
| Statistics as Topic | 2 | 2013 | 123 | 0.430 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2014 | 17 | 0.430 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2014 | 3 | 0.430 |
Why?
|
| Bulimia Nervosa | 1 | 2014 | 5 | 0.430 |
Why?
|
| Binge-Eating Disorder | 1 | 2014 | 8 | 0.420 |
Why?
|
| Suicide | 1 | 2016 | 140 | 0.420 |
Why?
|
| Heart | 4 | 2011 | 184 | 0.420 |
Why?
|
| Neural Pathways | 4 | 2009 | 138 | 0.420 |
Why?
|
| Myocardial Contraction | 2 | 2011 | 46 | 0.410 |
Why?
|
| Mood Disorders | 1 | 2014 | 54 | 0.410 |
Why?
|
| Terrorism | 1 | 2013 | 13 | 0.410 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2013 | 2 | 0.410 |
Why?
|
| CpG Islands | 5 | 2025 | 109 | 0.410 |
Why?
|
| Regression Analysis | 4 | 2018 | 490 | 0.410 |
Why?
|
| Potassium Channels | 1 | 2014 | 80 | 0.410 |
Why?
|
| Afghan Campaign 2001- | 5 | 2021 | 14 | 0.410 |
Why?
|
| Ankyrins | 1 | 2013 | 7 | 0.400 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2013 | 26 | 0.400 |
Why?
|
| Psychometrics | 3 | 2019 | 358 | 0.400 |
Why?
|
| Hydrocortisone | 3 | 2013 | 93 | 0.400 |
Why?
|
| Genetic Variation | 1 | 2016 | 430 | 0.390 |
Why?
|
| Reproducibility of Results | 7 | 2023 | 1081 | 0.390 |
Why?
|
| Family Conflict | 1 | 2013 | 13 | 0.390 |
Why?
|
| Vietnam Conflict | 3 | 2010 | 6 | 0.380 |
Why?
|
| Survivors | 3 | 2023 | 152 | 0.370 |
Why?
|
| Genetic Loci | 2 | 2024 | 104 | 0.360 |
Why?
|
| Personality Tests | 1 | 2011 | 7 | 0.350 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 386 | 0.350 |
Why?
|
| Rape | 2 | 2013 | 16 | 0.350 |
Why?
|
| Action Potentials | 6 | 2011 | 246 | 0.340 |
Why?
|
| Blast Injuries | 2 | 2021 | 6 | 0.340 |
Why?
|
| Neurotransmitter Agents | 3 | 2020 | 69 | 0.340 |
Why?
|
| Extremities | 2 | 2018 | 20 | 0.340 |
Why?
|
| Resilience, Psychological | 3 | 2017 | 106 | 0.330 |
Why?
|
| Periodicity | 2 | 2009 | 34 | 0.320 |
Why?
|
| Synapses | 3 | 2006 | 185 | 0.320 |
Why?
|
| Cohort Studies | 9 | 2025 | 1759 | 0.310 |
Why?
|
| Bioreactors | 4 | 2019 | 30 | 0.310 |
Why?
|
| Dendrites | 1 | 2009 | 57 | 0.310 |
Why?
|
| Personality Inventory | 5 | 2015 | 82 | 0.300 |
Why?
|
| Cross-Sectional Studies | 7 | 2026 | 3156 | 0.300 |
Why?
|
| Depression | 9 | 2023 | 863 | 0.300 |
Why?
|
| Repressor Proteins | 3 | 2020 | 273 | 0.300 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 1180 | 0.290 |
Why?
|
| Models, Theoretical | 1 | 2010 | 232 | 0.290 |
Why?
|
| Sex Factors | 5 | 2019 | 1028 | 0.290 |
Why?
|
| Obesity | 1 | 2017 | 1151 | 0.290 |
Why?
|
| Temperament | 3 | 2018 | 36 | 0.290 |
Why?
|
| Diseases in Twins | 3 | 2017 | 7 | 0.290 |
Why?
|
| Electric Stimulation | 4 | 2011 | 186 | 0.290 |
Why?
|
| Emotions | 4 | 2022 | 254 | 0.280 |
Why?
|
| Peripheral Nervous System | 3 | 2018 | 14 | 0.280 |
Why?
|
| Risk Factors | 8 | 2024 | 3994 | 0.280 |
Why?
|
| Case-Control Studies | 5 | 2020 | 1285 | 0.280 |
Why?
|
| Malingering | 2 | 2023 | 3 | 0.270 |
Why?
|
| Alleles | 3 | 2020 | 352 | 0.270 |
Why?
|
| Membrane Transport Modulators | 1 | 2007 | 4 | 0.270 |
Why?
|
| Aged, 80 and over | 7 | 2024 | 2853 | 0.270 |
Why?
|
| Factor Analysis, Statistical | 4 | 2015 | 162 | 0.260 |
Why?
|
| Species Specificity | 4 | 2018 | 286 | 0.260 |
Why?
|
| Multifactorial Inheritance | 2 | 2017 | 34 | 0.260 |
Why?
|
| Movement | 1 | 2007 | 119 | 0.240 |
Why?
|
| Tinnitus | 1 | 2026 | 4 | 0.240 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 94 | 0.240 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2018 | 42 | 0.240 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2006 | 55 | 0.240 |
Why?
|
| Sulpiride | 3 | 2014 | 6 | 0.230 |
Why?
|
| Internal-External Control | 3 | 2016 | 63 | 0.220 |
Why?
|
| Ammonia | 2 | 2015 | 22 | 0.220 |
Why?
|
| Neuronal Plasticity | 1 | 2006 | 126 | 0.220 |
Why?
|
| Nitrites | 2 | 2015 | 55 | 0.220 |
Why?
|
| Lymnaea | 2 | 2018 | 3 | 0.220 |
Why?
|
| Arousal | 6 | 2014 | 95 | 0.220 |
Why?
|
| Defense Mechanisms | 1 | 2004 | 10 | 0.220 |
Why?
|
| Nitrates | 2 | 2015 | 63 | 0.210 |
Why?
|
| Prevalence | 8 | 2020 | 1612 | 0.210 |
Why?
|
| Boston | 2 | 2014 | 32 | 0.210 |
Why?
|
| Personal Satisfaction | 2 | 2015 | 76 | 0.210 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 118 | 0.210 |
Why?
|
| Perfusion | 2 | 2020 | 38 | 0.210 |
Why?
|
| Circadian Rhythm | 1 | 2006 | 236 | 0.200 |
Why?
|
| Pain Clinics | 1 | 2023 | 4 | 0.200 |
Why?
|
| Phenotype | 4 | 2023 | 780 | 0.200 |
Why?
|
| Dopamine Antagonists | 3 | 2018 | 48 | 0.200 |
Why?
|
| Antisocial Personality Disorder | 2 | 2014 | 20 | 0.200 |
Why?
|
| Internal Capsule | 1 | 2023 | 3 | 0.200 |
Why?
|
| Wrist | 1 | 2023 | 7 | 0.200 |
Why?
|
| Biotin | 1 | 2003 | 24 | 0.200 |
Why?
|
| Appetite | 1 | 2003 | 21 | 0.200 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2023 | 26 | 0.190 |
Why?
|
| Anxiety | 5 | 2023 | 874 | 0.190 |
Why?
|
| Dreams | 1 | 2022 | 10 | 0.190 |
Why?
|
| Imagination | 1 | 2002 | 9 | 0.190 |
Why?
|
| Transcription, Genetic | 1 | 2025 | 592 | 0.190 |
Why?
|
| Electrophysiology | 3 | 2009 | 138 | 0.180 |
Why?
|
| Neuropsychological Tests | 3 | 2020 | 284 | 0.180 |
Why?
|
| Carrier Proteins | 1 | 2024 | 321 | 0.180 |
Why?
|
| Child Abuse | 1 | 2023 | 92 | 0.180 |
Why?
|
| Trauma Severity Indices | 2 | 2018 | 31 | 0.180 |
Why?
|
| Bayes Theorem | 1 | 2022 | 126 | 0.180 |
Why?
|
| Genomics | 3 | 2022 | 293 | 0.180 |
Why?
|
| Genome | 1 | 2022 | 149 | 0.170 |
Why?
|
| Cannabis | 1 | 2023 | 90 | 0.170 |
Why?
|
| Impulsive Behavior | 2 | 2018 | 55 | 0.170 |
Why?
|
| Apolipoproteins E | 2 | 2024 | 138 | 0.170 |
Why?
|
| Frontal Lobe | 2 | 2020 | 58 | 0.170 |
Why?
|
| Mollusca | 1 | 2020 | 17 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 252 | 0.170 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2020 | 14 | 0.160 |
Why?
|
| Adolescent | 8 | 2016 | 6081 | 0.160 |
Why?
|
| Corpus Striatum | 2 | 2018 | 121 | 0.160 |
Why?
|
| Sulfotransferases | 1 | 2020 | 9 | 0.160 |
Why?
|
| Gonads | 1 | 2020 | 21 | 0.160 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2019 | 5 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 116 | 0.150 |
Why?
|
| Organ Size | 2 | 2017 | 170 | 0.150 |
Why?
|
| Atrophy | 1 | 2019 | 51 | 0.150 |
Why?
|
| Sewage | 1 | 2019 | 27 | 0.150 |
Why?
|
| Pleurobranchaea | 1 | 2018 | 1 | 0.150 |
Why?
|
| Pilot Projects | 3 | 2017 | 760 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2024 | 863 | 0.150 |
Why?
|
| Interleukin-1alpha | 1 | 2018 | 18 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2020 | 174 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 91 | 0.140 |
Why?
|
| Sensory Receptor Cells | 1 | 2018 | 34 | 0.140 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 561 | 0.140 |
Why?
|
| Membrane Potentials | 2 | 2011 | 222 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2017 | 457 | 0.140 |
Why?
|
| Blinking | 2 | 2011 | 14 | 0.140 |
Why?
|
| Nerve Fibers | 1 | 2018 | 37 | 0.140 |
Why?
|
| Muscle Contraction | 2 | 2009 | 67 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 241 | 0.140 |
Why?
|
| Motor Vehicles | 3 | 2022 | 14 | 0.140 |
Why?
|
| Wounds and Injuries | 2 | 2020 | 193 | 0.130 |
Why?
|
| Registries | 2 | 2017 | 437 | 0.130 |
Why?
|
| Accidents, Traffic | 3 | 2022 | 48 | 0.130 |
Why?
|
| Suicide, Attempted | 2 | 2016 | 108 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 101 | 0.130 |
Why?
|
| Gambling | 1 | 2017 | 21 | 0.130 |
Why?
|
| Mechanoreceptors | 2 | 2009 | 17 | 0.130 |
Why?
|
| Triazines | 1 | 2017 | 25 | 0.130 |
Why?
|
| Pattern Recognition, Automated | 1 | 2017 | 32 | 0.130 |
Why?
|
| Analysis of Variance | 2 | 2009 | 575 | 0.130 |
Why?
|
| Reproduction | 2 | 2019 | 94 | 0.130 |
Why?
|
| Phylogeny | 1 | 2020 | 769 | 0.130 |
Why?
|
| Cues | 2 | 2009 | 81 | 0.120 |
Why?
|
| Sleep | 2 | 2023 | 185 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1070 | 0.120 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2006 | 80 | 0.120 |
Why?
|
| International Classification of Diseases | 1 | 2016 | 27 | 0.120 |
Why?
|
| Implosive Therapy | 1 | 2016 | 14 | 0.120 |
Why?
|
| Psychotherapy, Group | 1 | 2016 | 23 | 0.120 |
Why?
|
| Linear Models | 1 | 2017 | 317 | 0.120 |
Why?
|
| Myocardium | 2 | 2009 | 263 | 0.120 |
Why?
|
| Bacteria, Anaerobic | 1 | 2015 | 10 | 0.120 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2015 | 2 | 0.120 |
Why?
|
| Functional Laterality | 1 | 2015 | 89 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2017 | 258 | 0.120 |
Why?
|
| Histamine | 1 | 2015 | 19 | 0.120 |
Why?
|
| Water Purification | 1 | 2015 | 32 | 0.110 |
Why?
|
| Psychological Tests | 1 | 2015 | 56 | 0.110 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2014 | 12 | 0.110 |
Why?
|
| Patch-Clamp Techniques | 2 | 2007 | 228 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2020 | 456 | 0.110 |
Why?
|
| Glutaral | 1 | 2014 | 3 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 611 | 0.110 |
Why?
|
| Disease Progression | 1 | 2017 | 667 | 0.110 |
Why?
|
| Formaldehyde | 1 | 2014 | 31 | 0.110 |
Why?
|
| Coloring Agents | 1 | 2014 | 55 | 0.100 |
Why?
|
| Bombs | 1 | 2013 | 1 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 1124 | 0.100 |
Why?
|
| Explosions | 1 | 2013 | 6 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1604 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2015 | 172 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2004 | 207 | 0.100 |
Why?
|
| Hostility | 1 | 2013 | 7 | 0.100 |
Why?
|
| Electromyography | 2 | 2004 | 69 | 0.100 |
Why?
|
| Couples Therapy | 1 | 2013 | 3 | 0.100 |
Why?
|
| Child Abuse, Sexual | 1 | 2013 | 22 | 0.100 |
Why?
|
| Marriage | 1 | 2013 | 21 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 238 | 0.090 |
Why?
|
| Lead | 1 | 2013 | 100 | 0.090 |
Why?
|
| Borderline Personality Disorder | 1 | 2012 | 36 | 0.090 |
Why?
|
| Ligation | 1 | 2011 | 12 | 0.090 |
Why?
|
| Tetrodotoxin | 1 | 2011 | 22 | 0.090 |
Why?
|
| Sucrose | 1 | 2011 | 33 | 0.090 |
Why?
|
| Gene Regulatory Networks | 2 | 2024 | 149 | 0.090 |
Why?
|
| Ion Channel Gating | 1 | 2011 | 82 | 0.090 |
Why?
|
| Placebos | 1 | 2011 | 41 | 0.090 |
Why?
|
| Mental Status Schedule | 1 | 2010 | 18 | 0.080 |
Why?
|
| Environmental Exposure | 1 | 2013 | 256 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2011 | 317 | 0.080 |
Why?
|
| Reflex, Stretch | 1 | 2009 | 1 | 0.080 |
Why?
|
| Neurophysiology | 1 | 2009 | 10 | 0.080 |
Why?
|
| Portraits as Topic | 1 | 2009 | 2 | 0.080 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 4 | 0.080 |
Why?
|
| Microelectrodes | 1 | 2009 | 22 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 1067 | 0.080 |
Why?
|
| Pharynx | 1 | 2009 | 16 | 0.080 |
Why?
|
| Health Surveys | 3 | 2016 | 405 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2023 | 704 | 0.070 |
Why?
|
| Esophagus | 1 | 2009 | 42 | 0.070 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 66 | 0.070 |
Why?
|
| Photic Stimulation | 1 | 2009 | 125 | 0.070 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2012 | 298 | 0.070 |
Why?
|
| Veterans Disability Claims | 1 | 2008 | 1 | 0.070 |
Why?
|
| Eating | 1 | 2009 | 167 | 0.070 |
Why?
|
| Agoraphobia | 1 | 2008 | 17 | 0.070 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2008 | 25 | 0.070 |
Why?
|
| Sexual Behavior | 1 | 2013 | 638 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2008 | 73 | 0.070 |
Why?
|
| Cholinergic Agonists | 1 | 2007 | 6 | 0.070 |
Why?
|
| Cesium | 1 | 2007 | 8 | 0.070 |
Why?
|
| Carbachol | 1 | 2007 | 18 | 0.070 |
Why?
|
| Drug Administration Routes | 1 | 2007 | 14 | 0.070 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2007 | 12 | 0.070 |
Why?
|
| Conduct Disorder | 1 | 2007 | 54 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2023 | 638 | 0.060 |
Why?
|
| Reaction Time | 1 | 2007 | 157 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2006 | 55 | 0.060 |
Why?
|
| Galvanic Skin Response | 1 | 2006 | 17 | 0.060 |
Why?
|
| Dopamine Agents | 1 | 2006 | 28 | 0.060 |
Why?
|
| Health Policy | 1 | 2008 | 184 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2008 | 141 | 0.060 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2026 | 27 | 0.060 |
Why?
|
| Affective Symptoms | 1 | 2006 | 63 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2026 | 107 | 0.060 |
Why?
|
| Models, Neurological | 1 | 2006 | 136 | 0.060 |
Why?
|
| Psychomotor Performance | 1 | 2006 | 159 | 0.060 |
Why?
|
| Baclofen | 1 | 2004 | 9 | 0.060 |
Why?
|
| Child | 1 | 2013 | 3443 | 0.060 |
Why?
|
| Pheromones | 1 | 2004 | 18 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2007 | 373 | 0.050 |
Why?
|
| Systems Biology | 1 | 2024 | 27 | 0.050 |
Why?
|
| Pattern Recognition, Visual | 1 | 2004 | 36 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2025 | 104 | 0.050 |
Why?
|
| Neutrophils | 1 | 2025 | 145 | 0.050 |
Why?
|
| Mental Recall | 1 | 2004 | 84 | 0.050 |
Why?
|
| Peptides | 1 | 2007 | 372 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2025 | 189 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2024 | 199 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2004 | 125 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2024 | 2544 | 0.050 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2004 | 61 | 0.050 |
Why?
|
| Anisotropy | 1 | 2023 | 33 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2003 | 30 | 0.050 |
Why?
|
| Peripheral Nerves | 1 | 2003 | 14 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2023 | 91 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 497 | 0.050 |
Why?
|
| Attention | 1 | 2004 | 174 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2022 | 103 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2002 | 39 | 0.050 |
Why?
|
| Prognosis | 1 | 2025 | 861 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2022 | 165 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2002 | 240 | 0.040 |
Why?
|
| Kynurenine | 1 | 2020 | 8 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 266 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 384 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2020 | 55 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 278 | 0.040 |
Why?
|
| Leukocytes | 1 | 2020 | 80 | 0.040 |
Why?
|
| Pain | 1 | 2023 | 290 | 0.040 |
Why?
|
| Brain Concussion | 1 | 2020 | 36 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1271 | 0.040 |
Why?
|
| Neurosecretory Systems | 1 | 2019 | 17 | 0.040 |
Why?
|
| RNA Interference | 1 | 2020 | 247 | 0.040 |
Why?
|
| Antibodies | 1 | 2019 | 144 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2020 | 310 | 0.040 |
Why?
|
| Solubility | 1 | 2019 | 139 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2019 | 86 | 0.040 |
Why?
|
| Dopamine Agonists | 1 | 2018 | 34 | 0.040 |
Why?
|
| Personality Assessment | 1 | 2018 | 45 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 436 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 1600 | 0.030 |
Why?
|
| Lateral Ventricles | 1 | 2017 | 11 | 0.030 |
Why?
|
| Thalamus | 1 | 2017 | 34 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2017 | 61 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2020 | 972 | 0.030 |
Why?
|
| Insulin | 1 | 2019 | 258 | 0.030 |
Why?
|
| Smoking | 1 | 2023 | 1024 | 0.030 |
Why?
|
| Anaerobiosis | 1 | 2015 | 18 | 0.030 |
Why?
|
| Ganglia | 1 | 2015 | 12 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 701 | 0.030 |
Why?
|
| Rest | 1 | 2015 | 32 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2004 | 2157 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 1772 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 1869 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2015 | 137 | 0.030 |
Why?
|
| Temperature | 1 | 2015 | 313 | 0.030 |
Why?
|
| Death, Sudden | 1 | 2013 | 4 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2013 | 78 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 269 | 0.020 |
Why?
|
| Awareness | 1 | 2013 | 73 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 67 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2013 | 114 | 0.020 |
Why?
|
| Saliva | 1 | 2013 | 119 | 0.020 |
Why?
|
| Sex Offenses | 1 | 2012 | 45 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 440 | 0.020 |
Why?
|
| Bacteria | 1 | 2014 | 293 | 0.020 |
Why?
|
| Twins | 1 | 2010 | 19 | 0.020 |
Why?
|
| Self Concept | 1 | 2011 | 171 | 0.020 |
Why?
|
| Australia | 1 | 2010 | 103 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2009 | 9 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 236 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2009 | 45 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2009 | 35 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 2009 | 35 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1857 | 0.020 |
Why?
|
| Mice | 1 | 2020 | 6644 | 0.020 |
Why?
|
| Visual Perception | 1 | 2009 | 80 | 0.020 |
Why?
|
| Twin Studies as Topic | 1 | 2007 | 3 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1596 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2007 | 162 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 408 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 509 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 52 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1542 | 0.010 |
Why?
|